425: Strive & Semler Scientific Merger: Cautionary Update

Strive, Inc. issued a cautionary statement regarding its proposed business combination with Semler Scientific, Inc., highlighting inherent risks and uncertainties.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc.
• The communication was posted on X.com by Matthew Cole, CEO of Strive, on September 23, 2025.
• The filing primarily serves as a cautionary statement regarding forward-looking statements concerning the merger.
• It outlines various risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Strive intends to file a Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, with the SEC to register shares and seek Semler Scientific stockholder approval.

Sentiment

Score: 4

Explanation: The filing is primarily a legal disclosure and cautionary statement regarding a proposed merger. While a merger itself can be positive, the extensive list of risks and uncertainties, and the explicit mention of potential negatives like dilution and delays, contribute to a cautious to slightly negative sentiment, rather than overtly positive.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are expected from the merger.

Negatives

• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities is possible.
• Potential for dilution caused by Strive's issuance of additional Class A common stock in connection with the transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers.
• Possible changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could occur.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing discusses the outlook and expectations of Strive and Semler Scientific regarding the proposed transaction, including anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, and the timing of the closing. However, it heavily emphasizes that these are forward-looking statements subject to significant risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted a communication on X.com on September 23, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

This filing is a standard regulatory disclosure related to a proposed merger, reflecting the procedural steps and extensive risk disclosures common in M&A activities for publicly traded companies. It touches upon the integration of a company with a focus on Bitcoin treasury strategies, indicating a potential trend in corporate asset management.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is referenced as being set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders: Potential for dilution from Strive's share issuance; need to approve the transaction; share price changes before closing.
• Customers: Potential adverse reactions from Strive's or Semler Scientific's customers.
• Employees: Potential changes to business or employee relationships.
• Management: Diversion of management's attention from ongoing business operations and opportunities.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, risk factors, corporate governance, Bitcoin treasury, digital assets